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Background: Tigecycline, a member of a new class of
antimicrobials (glycylcyclines), has been shown to have
potent broad spectrum activity against most commonly
encountered species responsible for hospital acquired infec-
tions. Cross-resistance to several classes of antimicrobials
is often seen in nosocomial pathogens. The T.E.S.T. pro-
gram determined the in vitro activity of tigecycline against
strains of Enterobacteriaceae cross-resistant to one or
more of the following antimicrobials: amoxicillin-clavulanic
acid, piperacillin-tazobactam, levoﬂoxacin, ceftriaxone,
cefepime, ampicillin, amikacin, minocycline, ceftazidime
and imipenem. The isolates were collected from 335 inves-
tigational sties in 47 countries throughout 2004—2007.
Methods: A total of 26,791 clinical Enterobacteriaceae
were identiﬁed to the species level at each site and
conﬁrmed by the central laboratory. Minimum Inhibitory
Concentrations (MICs) were determined by the local lab-
oratory using broth microdilution panels. Antimicrobial
resistance was interpreted according to CLSI breakpoints
with TIG susceptible and resistant breakpoints deﬁned
as = 8mcg/ml, respectively.
Results: 1,387/16,289 (8.5%) E. coli and Klebsiella spp
were ESBL producers. Of the Enterobacteriaceae presented,
13% were resistance to levoﬂoxacin, 8% to minocycline,
1.1% to amikacin, 0.2% to imipenem, and 0.8% to tigecy-
cline. Of the 10,348 Enterobacter spp. and S. marcescens
collected, 593 (5.7%) presented resistance to ceftriaxone
and ceftazidime but susceptible to cefepime suggestive of
AmpC phenotype. Only 877 (3.3%) of the Enterobacteriaceae
showed any degree of non-susceptibility against tigecycline
with MICs ranging from 4 to 8mcg/mL. Tigecycline also
showed excellent inhibitory activity against members of
Enterobacteriaceae that were resistant to amikacin, lev-
oﬂoxacin, minocycline and imipenem inhibiting 94%, 92%,
72% and 91% of isolates respectively.
Conclusions: The presented data suggest that tigecycline
is little affected by this cross-resistance phenomenon and
may be an effective and reliable therapeutic option against
nosocomial or community pathogens regardless to the resis-
tance patterns.
doi:10.1016/j.ijid.2008.05.298
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This study describes the pattern and extent of drug resis-
tance in 1774 strains of Salmonella enterica serovar Typhi (S.
Typhi) isolated across Asia between 1993 and 2005 and char-
acterizes the molecular mechanisms underlying the reduced
susceptibility to the ﬂuoroquinolones in these strains. In
1393 S. Typhi collected in southern Vietnam, the propor-
tion of MDR has remained at high levels since 1993 (50% in
2004) and there was a dramatic increase in nalidixic acid
resistance between 1993 (4%) and 2005 (97%). In a cross-
sectional sample of 381 S. Typhi from 8 Asian countries,
Bangladesh, China, India, Indonesia, Laos, Nepal, Pakistan
and central Vietnam collected in 2002 to 2004, variable
rates of multidrug resistance (16—37%) and nalidixic acid
resistance (5—51%) were found. The eight Asian countries
involved in this study are home to approximately 80% of
the world’s typhoid fever cases. These results document the
scale of drug resistance across Asia.
The Ser83♦Phe substitution in GyrA was the predomi-
nant alteration in S. Typhifrom Vietnam (117/127 isolates,
92.1%). No mutations in gyrB, parC and parE were detected
in 55 of these strains. In vitro time-kill experiments showed
a reduction in the efﬁcacy of oﬂoxacin against strains har-
bouring a single amino acid substitution at codon 83 or 87
of GyrA, this effect was more marked against a strain with
a double substitution. The 8-methoxy ﬂuoroquinolone gati-
ﬂoxacin showed rapid killing of S. Typhi harbouring both the
single and double amino acid substitutions.
doi:10.1016/j.ijid.2008.05.299
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Background: The intrinsic resistance of Pseudomonas
aeruginosa towards several antimicrobial agents has con-
tributed to its role as an effective opportunistic pathogen
and its emergence as one of the most problematic human
pathogens. The aim of this study was to assess the suscepti-
bility patterns of eight commonly used antimicrobial agents
against clinical isolates of Pseudomonas aeruginosa.
13th International Congress on Infectious Diseases Abstracts, Poster Presentations e121
Methods: A total of 97 Pseudomonas aeruginosa strains
were isolated from various clinical specimens at the Kuala
Lumpur Hospital, Malaysia between October and December
2007. Antimicrobial susceptibility was determined using the
E-test method subsequent to the hospital’s routine diagnos-
tic testing by the disk diffusion (DD) method. Results were
interpreted according to the Clinical and Laboratory Stan-
dards Institute (CLSI) guidelines.
Results: Total agreement of DD and E-test methods
was 99% for susceptibility to gentamicin, ciproﬂoxacin
and ceftazidime, 98% for susceptibility to amikacin,
piperacillin/tazobactam, imipenem and meropenem and
97% for susceptibility to cefepime. According to the
E-test method, the rates of susceptible isolates were
piperacillin/tazobactam 91%, amikacin 87%, gentamicin
85%, ciproﬂoxacin 84%, ceftazidime and cefepime 80% each,
imipenem 79% and meropenem 77%. 24% of the isolates were
resistant to two or more antimicrobial agents.
Conclusion: The E-test and DD methods showed high
agreement in determining the in vitro activity of the
antimicrobial agents on the Pseudomonas aeruginosa iso-
lates. Although the DD method is more cost effective for
routine hospital use, the E-test is rapid, easy to per-
form and has an added ability to determine MIC value.
Piperacillin/tazobactam was the most active antimicrobial
agent in vitro against Pseudomonas aeruginosa, followed
by the aminoglycosides (amikacin and gentamicin). By con-
trast, the quinolone (ciproﬂoxacin) and the beta-lactams
(meropenem, imipenem, cefepime and ceftazidime)were
the least active antimicrobial agents. Periodical surveillance
study of such provides very useful data on the overall situa-
tion in a hospital.
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Background: AmpC class beta lactamases are
cephalosporinases that are poorly inhibited by clavu-
lanic acid. They are different from other ESBLs by their
ability to hydrolyze Cephamycins (cefoxitin,cefotetan)
in addition to other extended spectrum cephalosporins.
Plasmid mediated Amp C beta lactamases differ from
chromosomal AmpCs in being uninducible and are typically
associated with broad multi drug resistance. Information on
the prevalence of AmpC beta lactamase producing strains
from India is scanty.
Here in we report a study done on gram negative bacilli
for AmpC detection using the previously reported AmpC disk
test from a tertiary public health care centre of North India.
Methods: The strains of gram negative bacilli included
42 Klebsiella pneumoniae, 2 Klebsiella oxytoca, 6 Proteus
mirabilis, 100 Salmonella typhi and 39 E. coli. Resistance to
cefoxitin was ﬁrst seen determined by disc diffusion test.
Only cefoxitin resistant isolates were further processed for
AmpC detection by the method of Amp C disc test. Positive
results were read as any indentation or ﬂattening of the
zone of inhibition. All the strains were also simultaneously
checked for ESBL production.
Results: Cefoxitin resistance was not detected in any
strain of Salmonella. Out of remaining 50 isolates exclud-
ing E. coli, Amp C was detected in 15 isolates-13 Klebsiella
pneumoniae, 1 Klebsiella oxytoca and 1 Proteus mirabilis.
10 showed indentation and 5 showed ﬂattening of the
zones. All the isolates were sensitive to Imipenem and vari-
ably sensitive to ciproﬂoxacin, cefoperazone-sulbactam and
aminoglycosides. Also regarding E. coli isolates 15 out of 39
showed AmpC disc test positivity.
Conclusion: 15/50 i.e (30%) of the Klebsiella pneumo-
niae, Klebsiella oxytoca, and Proteus mirabilis showed
prescence of AmpC from our centre, which is most proba-
bly plasmid mediated as these organisms lack chromosomal
AmpC. As regards E. coli, percentage positivity is about 45%,
but these could be plasmid or chromosomal.
doi:10.1016/j.ijid.2008.05.301
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Background: Pseudomonas aeruginosa, recognized as
human opportunistic pathogen is increasingly responsible
for lethal nosocomial infections. Treatment options are dra-
matically declining worldwide. This species has emerged as
a relevant animal pathogen too. This is a consequence of
massive antibiotic use and the large versatile genome of
this organism. Antimicrobial proﬁling of P. aeruginosa ani-
mal isolates may contribute to a better understanding of the
development and the epidemiology of P. aeruginosa multi-
drug resistance in our densely populated biosphere with
increasing human-animal interactions.
Methods: This work characterized 66 P. aeruginosa
clinical isolates originating from diverse animals (horses,
cows, sea turtles, dolphins, cats, parrots, canguru,
etc.) using amongst others fAFLP (ﬂuorescent Ampliﬁed
Fragment Length Polymorphisms) ﬁngerprinting. Suscepti-
bility to 21 antibiotics (amikacin, amoxicillin/clavulanic
acid, ampicillin, chloranfenicol, carbenicillin, ceftazidime,
